Keryx Biopharmaceuticals, Inc. (KERX) Posts Q3 Loss of $0.15
Tweet Send to a FriendGet Alerts KERX Hot Sheet
Price: $8.24 +7.57%
EPS Growth %: +76.9%
Financial Fact:
Operating loss: -2.16M
Today's EPS Names:
IHS, MEI, PIR, More
EPS Growth %: +76.9%
Financial Fact:
Operating loss: -2.16M
Today's EPS Names:
IHS, MEI, PIR, More
Trade KERX Now!
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) reported Q3 EPS of ($0.15), $0.03 worse than the analyst estimate of ($0.12).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Steelcase Inc. (SCS) Misses Q1 EPS by 3c, Q2 Guidance Light
- Micron Technology, Inc. (MU) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
